These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2954790)

  • 41. Ifosfamide: a weekly dose fractionated schedule in bronchogenic carcinoma.
    Morgan LR; Posey LE; Rainey J; Bickers J; Ryan D; Vial R; Hull EW
    Cancer Treat Rep; 1981; 65(7-8):693-5. PubMed ID: 6265084
    [No Abstract]   [Full Text] [Related]  

  • 42. [Bronchial cancer: possibilities and limits of chemotherapy. 2: Non-small cell bronchial cancer].
    Schalhorn A
    Fortschr Med; 1985 May; 103(17):453-6. PubMed ID: 4039699
    [No Abstract]   [Full Text] [Related]  

  • 43. Combination chemotherapy for non-small cell bronchogenic carcinoma with bleomycin, doxorubicin, methotrexate, and cis-dichlorodiammineplatinum(II) (BAMP).
    Vogl SE; Wollner D; Kaplan BH; Berenzweig M
    Cancer Treat Rep; 1980; 64(4-5):717-9. PubMed ID: 6159081
    [No Abstract]   [Full Text] [Related]  

  • 44. High-dose cisplatin with fluid and mannitol-induced diuresis in advanced lung cancer: a phase II clinical trial of the EORTC Lung Cancer Working Party (Belgium).
    De Jager R; Longeval E; Klastersky J
    Cancer Treat Rep; 1980; 64(12):1341-6. PubMed ID: 6258791
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapy of bronchogenic carcinoma with the drug platidiam lachema.
    Kolek V; Kroutilová J; Minarík J; Zák J
    Acta Univ Palacki Olomuc Fac Med; 1986; 114():275-83. PubMed ID: 3022563
    [No Abstract]   [Full Text] [Related]  

  • 46. Chemotherapy for inoperable, non-small cell bronchogenic carcinoma: EST 2575, generation II.
    Ruckdeschel JC; Mehta CR; Salazar OM; Cohen M; Vogl S; Koons LS; Lerner H
    Cancer Treat Rep; 1981; 65(11-12):965-72. PubMed ID: 7028258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 4'-Epidoxorubicin plus cisplatin as first-line therapy in the treatment of small cell bronchogenic carcinoma.
    Lelli G; Casadio M; Giordani S; Giuliotti C; Canova N; Martoni A; Pannuti F
    Chemioterapia; 1987 Apr; 6(2):134-6. PubMed ID: 3036379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical and histopathological considerations on intra-arterial cisplatin therapy followed by surgery in the management of squamous cell carcinoma of the oral cavity and oropharynx].
    Comoretto R; Grigoletto E; Delendi N; Quadu G; Barzan L; Frustaci S; Godeassi F; Tumolo S
    Acta Otorhinolaryngol Ital; 1983; 3(2):159-65. PubMed ID: 6683922
    [No Abstract]   [Full Text] [Related]  

  • 49. Preoperative treatment of squamous cell carcinoma of the lung with mitomycin-C in the bronchial artery.
    Ekholm SE; Dahlbäck O; Tylén U
    Eur J Radiol; 1986 Feb; 6(1):9-11. PubMed ID: 3084258
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of chemotherapy in lung cancer (controlled trials).
    Shnider BI
    Med Ann Dist Columbia; 1971 Aug; 40(8):489-95. PubMed ID: 5001653
    [No Abstract]   [Full Text] [Related]  

  • 51. [Cytostatic therapy of tumors of the lung].
    De Marco F; Saviano G; Tenore G
    Arch Monaldi; 1974; 29(3-4):326-35. PubMed ID: 4463917
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical evaluation of an innoxious antineoplastic agent: preliminary study of 106 patients treated with or without RSV after pulmonary resection for bronchogenic carcinoma.
    Hansen JL
    Cancer Chemother Rep 3; 1973 Mar; 4(2):261-4. PubMed ID: 4729327
    [No Abstract]   [Full Text] [Related]  

  • 53. Cisplatin-induced autonomic neuropathy.
    Rosenfeld CS; Broder LE
    Cancer Treat Rep; 1984 Apr; 68(4):659-60. PubMed ID: 6538810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Phase II study of bronchial artery infusion of mitomycin C in non-small cell lung cancer].
    Nakamura Y; Shimizu E; Hohjo F; Hashimoto Y; Mutsuura S; Yamasaki K; Mukai J; Tada T; Sone S; Yamashita T
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3436-9. PubMed ID: 3024579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infusion versus perfusion.
    Golomb FM
    Aktuelle Probl Chir; 1970; 14():835-57. PubMed ID: 4124391
    [No Abstract]   [Full Text] [Related]  

  • 56. Cisplatin combination chemotherapy in non-oat cell carcinoma of the lung.
    Vincent RG; Lane WW; Raza S; Madajewicz S
    Cancer Treat Rep; 1982 Jan; 66(1):197-8. PubMed ID: 6975658
    [No Abstract]   [Full Text] [Related]  

  • 57. [The clinicopathological effects of infusion of cis-platinum into the bronchial artery on lung cancer].
    Matsumura K; Sawada K; Ishida I; Seki Y; Fukuma S; Kuwabara T; Maruyama T
    Gan No Rinsho; 1985 Mar; 31(3):240-5. PubMed ID: 2987565
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-dose intra-arterial cisplatin therapy followed by radiation therapy for advanced squamous cell carcinoma of the head and neck.
    Wilson WR; Siegel RS; Harisiadis LA; Davis DO; Nguyen HH; Bank WO
    Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):809-12. PubMed ID: 11448355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phase II study of the effect of methyl-CCNU (NSC-95441) on bronchogenic carcinoma.
    Takita H; Brugarolas A; Mittelman A; Vincent R
    Cancer Chemother Rep 3; 1973 Mar; 4(2):257-9. PubMed ID: 4125743
    [No Abstract]   [Full Text] [Related]  

  • 60. Double blood supply of bronchogenic carcinoma from multiple arteries.
    Hellekant C; Jonsson K
    Acta Radiol Diagn (Stockh); 1981; 22(4):403-6. PubMed ID: 7331852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.